Hi-Tech Pharma Enters Oversold Territory - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Hi-Tech Pharmacal Co. 's ( HITK ) share price has entered into oversold territory with a stochastic value of 13.278. The Zacks Consensus Estimate on the company's earnings for the year ending April 2012 increased by 21 cents over the past two months to $3.82 per share. Hi-Tech Pharmacal is a Zacks #2 Rank ("Buy") company.

HI TECH PHARMA ( HITK ): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: HITK

More from Zacks.com




Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com